Gastric Cancer
📧 Sign up to get email alerts when something new happens for Gastric Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-12-05Clinical Trial Update: ACE1702 in Subjects With Advanced or Metastatic HER2-expressing Solid Tumors [Phase 1]
An update on a Phase 1 trial of ACE1702 for advanced or metastatic HER2-expressing solid tumors; the study status is completed.
-
CLINICAL_TRIALS trial_result · 2024-12-05Clinical Trial Update: Tusamitamab Ravtansine (SAR408701) in Combination With Ramucirumab in Pretreated Participants With Gastric Cancer [Phase 2]
A Phase 2 study evaluating tusamitamab ravtansine in combination with ramucirumab for pretreated gastric or gastroesophageal cancer has been…
-
CLINICAL_TRIALS trial_result · 2024-12-04Clinical Trial Update: Trajectory of Body Composition Identifies LAGC with Cachexia Following NACT
A completed clinical trial update reports that body composition trajectory may identify locally advanced gastric cancer patients who develop…
-
CLINICAL_TRIALS trial_result · 2024-12-02Clinical Trial Update: A Study of IMAB362 in Japanese Subjects With Locally Advanced or Metastatic Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma [NA]
Clinical trial update for IMAB362 (zolbetuximab) in Japanese patients with locally advanced or metastatic gastric or GEJ adenocarcinoma; the…
-
CLINICAL_TRIALS trial_result · 2024-11-29Clinical Trial Update: Effect of Helicobacter Pylori Eradication After Subtotal Gastrectomy on Survival Rate of Gastric Cancer Patients: Retrospective Study
A completed retrospective study assessed whether Helicobacter pylori eradication after subtotal gastrectomy influences survival in gastric c…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-11-29Clinical Trial Update: Study of BO-112 With Pembrolizumab for Colorectal or Gastric/GEJ Cancer With Liver Metastasis [Phase 2]
A Phase 2 study evaluating BO-112 in combination with pembrolizumab for colorectal and gastric/GEJ cancers with liver metastasis has been te…
-
CLINICAL_TRIALS trial_result · 2024-11-29Clinical Trial Update: Fibrin Glue After ESD for High Risk Patients of Bleeding [NA]
The clinical trial update reports the completion of a study evaluating the use of fibrin glue after endoscopic submucosal dissection in high…
-
CLINICAL_TRIALS trial_result · 2024-11-26Clinical Trial Update: Evaluate the Prognostic Significance of Changes in the Systemic Immune-Inflammation Index in Patients with AGC Treated with ICI Therapy.
A completed clinical study evaluating whether changes in the Systemic Immune-Inflammation Index predict outcomes in patients with gastric ca…
-
CLINICAL_TRIALS trial_result · 2024-11-26Clinical Trial Update: Trastuzumab, Bevacizumab with Paclitaxel for HER2-positive Gastric Cancer in a Second-line Therapy [Phase 1, Phase 2]
Clinical trial update indicating ongoing recruitment for a Phase 1/2 study of trastuzumab, bevacizumab, and paclitaxel in HER2-positive adva…
-
CLINICAL_TRIALS trial_result · 2024-11-25Clinical Trial Update: The Number of Mesogastria Containing Metastatic Lymph Nodes Predicts Gastric Cancer Prognosis
A completed clinical trial update suggests that the number of mesogastric lymph nodes containing metastases may predict prognosis in gastric…
-
CLINICAL_TRIALS trial_result · 2024-11-25Clinical Trial Update: A Study of NDI 1150-101 in Patients With Solid Tumors [Phase 1, Phase 2]
Nimbus Saturn, Inc. is conducting a Phase 1/2 trial of NDI 1150-101 in patients with solid tumors, including renal cell carcinoma, gastric c…
-
CLINICAL_TRIALS trial_result · 2024-11-21Clinical Trial Update: Study of T-DXd Monotherapy in Patients With HER2-expressing Locally Advanced or Metastatic Gastric or GEJ Adenocarcinoma Who Have Received 2 or More Prior Regimens [Phase 2]
Phase 2 study evaluating trastuzumab deruxtecan monotherapy in HER2-expressing gastric or GEJ adenocarcinoma after two or more prior regimen…
-
CLINICAL_TRIALS trial_result · 2024-11-20Clinical Trial Update: Impact of TTC Following Neoadjuvant Chemotherapy on the Prognosis of LAGC
This clinical trial update assesses the impact of TTC after neoadjuvant chemotherapy on prognosis in locally advanced gastric cancer.
-
CLINICAL_TRIALS trial_result · 2024-11-20Clinical Trial Update: A Pharmacokinetic Study of Zolbetuximab (IMAB362) in Chinese Subjects With Locally Advanced Unresectable or Metastatic Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma [Phase 1]
This clinical trial update notes the completion of a Phase 1 pharmacokinetic study of zolbetuximab (IMAB362) in Chinese patients with locall…
-
CLINICAL_TRIALS trial_result · 2024-11-19Clinical Trial Update: The Incidence of Gallstones After Gastrectomy [NA]
A completed clinical trial reports the incidence of gallstones after gastrectomy in patients with gastric cancer.
-
CLINICAL_TRIALS trial_result · 2024-11-19Clinical Trial Update: The Incidence of Gallstones After Gastric Cancer Surgery
A completed study assessed the incidence of gallstones after gastric cancer surgery. The trial was sponsored by the Hepatopancreatobiliary S…
-
CLINICAL_TRIALS trial_result · 2024-11-14Clinical Trial Update: Safety and Activity of IMAB362 in Combination With Zoledronic Acid and Interleukin-2 in CLDN18.2-positive Gastric Cancer [Phase 1]
Phase 1 study assessing safety and activity of IMAB362 (zolbetuximab) in combination with zoledronic acid and interleukin-2 in CLDN18.2-posi…
-
CLINICAL_TRIALS trial_result · 2024-11-14Clinical Trial Update: A Study to Explore the Efficacy and Safety of Atezolizumab Plus Tiragolumab and Chemotherapy in 1st Line HER2 Negative Unresectable, Recurrent or Metastatic Gastric Cancer or Adenocarcinoma of Gastroesophageal Junction (GEJ) [Phase 2]
A Phase 2 trial evaluating atezolizumab plus tiragolumab with chemotherapy in first-line HER2-negative unresectable, recurrent, or metastati…
-
CLINICAL_TRIALS trial_result · 2024-11-14Clinical Trial Update: Anastomotic Leak Testing in Gastrectomy [NA]
This is a completed clinical trial update from Nanchong Central Hospital. It concerns testing for anastomotic leak after gastrectomy in pati…
-
CLINICAL_TRIALS trial_result · 2024-11-12Clinical Trial Update: Chemotherapy Alone vs. Chemotherapy + Surgical Resection in Patients With Limited-metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction [Phase 3]
Phase 3 trial comparing chemotherapy alone versus chemotherapy plus surgical resection for limited-metastatic gastric cancer or gastroesopha…
-
CLINICAL_TRIALS trial_result · 2024-11-12Clinical Trial Update: Mecapegfilgrastim Combined With Adebrelimab and Chemotherapy as Neoadjuvant Therapy in Resectable GC/GEJC [Phase 2]
A Phase 2 clinical trial is evaluating mecapegfilgrastim combined with adebrelimab and chemotherapy as neoadjuvant therapy for resectable ga…
-
CLINICAL_TRIALS trial_result · 2024-11-05Clinical Trial Update: Comparison of Long-term Outcomes Between Upfront Surgery and Neoadjuvant Therapy Followed by Surgery in Patients with Node-Negative Gastric Cancer
This completed clinical trial compares upfront surgery with neoadjuvant therapy followed by surgery for node-negative gastric cancer and rep…
-
CLINICAL_TRIALS trial_result · 2024-11-04Clinical Trial Update: Nab-paclitaxel Plus PD-1 Inhibitor Versus Nab-paclitaxel As Second-line Treatment in Advanced Gastric Cancer [Phase 2]
A Phase 2 trial comparing nab-paclitaxel plus a PD-1 inhibitor versus nab-paclitaxel alone as second-line therapy in advanced gastric and ga…
-
CLINICAL_TRIALS trial_result · 2024-10-31Clinical Trial Update: Octreotide Treatment to Improve Nutritional Recovery After Surgery for Patients with Esophageal or Gastric Cancer [Phase 2]
Phase 2 trial evaluating octreotide to improve nutritional recovery after surgery in patients with esophageal or gastric cancer has complete…
-
CLINICAL_TRIALS trial_result · 2024-10-30Clinical Trial Update: Real-world Data of Paclitaxel and Ramucirumab Compared to Other Treatment Regimens in Advanced Gastric Cancer
This completed real-world data study compares paclitaxel plus ramucirumab against other regimens in second-line treatment of advanced gastri…